Developing therapeutic antibody drugs is a lengthy, highly explorative process. There are many potential pitfalls, challenges, and risks during drug development, which can significantly impact the ...

AstraZeneca's MFN pricing agreement with the US government reflects broader efforts to reduce drug prices and enhance ...

Quality control errors during pharmaceutical manufacturing are unfortunately common occurrences. The majority (around 50%) of employees that work in pharmaceutical manufacturing tend to have duties ...

Recent articles have prompted questions about the quality of the nation's drug supply. Michael Kopcha, PhD, a registered pharmacist and the director of the Office of Pharmaceutical Quality at the FDA, ...

The biopharmaceutical industry has grown remarkably in recent years, with cell and gene therapy (CGT) emerging as a key area amidst continuous technological advancements. As biologics dominate ...

A year after the FDA found shredded quality documents at an Intas Pharmaceuticals drug manufacturing facility in India, Intas’ parent company Accord Healthcare resumed making cisplatin, which has been ...

The top 10 PharmTech videos of the year cover advanced therapies, high-concentration biologics, major mergers and ...

The trade in substandard and counterfeit medicines in India continues to raise concerns, with recent reports highlighting multiple drugs failing to meet quality standards and a few being identified as ...

These samples were part of a larger batch of 200 drugs tested nationwide that were found to be below standard, prompting the ...

Over the last five years, drug regulators tested more than 4.9 lakh samples of medicines, including cough syrups, ORS, ...

No articles found. Fujian Institute for Food and Drug Quality Control did not contribute to any primary research papers from Nature Index journals in the current 12 month window. The following ...